Vol 3, No 2 (2000)
Basic sciences
Published online: 2003-05-27
Submitted: 2012-01-23
Get Citation

New derivatives of 2-(N-arylmethylideneamine) benzophenone oxime as potential radiopharmaceuticals for brain imaging

Elżbieta Mikiciuk-Olasik, Elżbieta Żurek, Renata Mikołajczak, Edyta Zakrzewska, Katarzyna Błaszczak-Świątkiewicz
Nucl. Med. Rev 2000;3(2):149-152.
Vol 3, No 2 (2000)
Basic sciences
Published online: 2003-05-27
Submitted: 2012-01-23

Abstract

BACKGROUND: The aim of this work was the development of a sufficient method for synthesis and radiolabelling with technetium- 99m a new class of compounds as potential ligands for brain imaging.
METHODS: The synthesis of new ligands with the structure of 2-(N-arylmethylideneamine) benzophenone oxime (6?10) based on the cyclocondensation of appropriate 2-aminobenzophenone oxime 1?2 with respective aldehydes 3?4 or ketone 5 in acidic conditions. During our experiments in dependencies from the reaction conditions, compounds with the structure of Schiff?s bases (6?10) or 3N-oxides 1,2-dihrydroquinazoline derivatives were obtained. Labelling of compounds 6 or 7 with technetium- 99m was done by stannous chloride reduction according to two methods (in ethyl alcohol or in chloroform) following the radiolabelling method of HM-PAO. The complex 99mTc-HM-PAO was the leading compound in our computational calculations with geometrical optimisation of a molecule. Using molecular modelling (semi-empirical method ZINDO) we have determined the electrostatic potential for the obtained ligands. Additionally we have calculated total energy,binding energy, heat of formation and several 3D-QSAR parameters for theoretically possible complexes of 99mTc with the obtained ligands.
RESULTS: As a result of our experiments a method of a synthesis of new compounds 6 and 7 has been developed. Computational calculations were performed using the HyperChem 4.5 program. These calculations confirmed our hypothesis that only ligand 7 is able to form a complex with 99mTc and this complex possesses lipophilic properties.
CONCLUSIONS: Complex 99mTc-7, due to its lipophilic properties, is a potential radiopharmaceutical for the brain imaging.

Abstract

BACKGROUND: The aim of this work was the development of a sufficient method for synthesis and radiolabelling with technetium- 99m a new class of compounds as potential ligands for brain imaging.
METHODS: The synthesis of new ligands with the structure of 2-(N-arylmethylideneamine) benzophenone oxime (6?10) based on the cyclocondensation of appropriate 2-aminobenzophenone oxime 1?2 with respective aldehydes 3?4 or ketone 5 in acidic conditions. During our experiments in dependencies from the reaction conditions, compounds with the structure of Schiff?s bases (6?10) or 3N-oxides 1,2-dihrydroquinazoline derivatives were obtained. Labelling of compounds 6 or 7 with technetium- 99m was done by stannous chloride reduction according to two methods (in ethyl alcohol or in chloroform) following the radiolabelling method of HM-PAO. The complex 99mTc-HM-PAO was the leading compound in our computational calculations with geometrical optimisation of a molecule. Using molecular modelling (semi-empirical method ZINDO) we have determined the electrostatic potential for the obtained ligands. Additionally we have calculated total energy,binding energy, heat of formation and several 3D-QSAR parameters for theoretically possible complexes of 99mTc with the obtained ligands.
RESULTS: As a result of our experiments a method of a synthesis of new compounds 6 and 7 has been developed. Computational calculations were performed using the HyperChem 4.5 program. These calculations confirmed our hypothesis that only ligand 7 is able to form a complex with 99mTc and this complex possesses lipophilic properties.
CONCLUSIONS: Complex 99mTc-7, due to its lipophilic properties, is a potential radiopharmaceutical for the brain imaging.
Get Citation

Keywords

radiopharmaceuticals; brain imaging

About this article
Title

New derivatives of 2-(N-arylmethylideneamine) benzophenone oxime as potential radiopharmaceuticals for brain imaging

Journal

Nuclear Medicine Review

Issue

Vol 3, No 2 (2000)

Pages

149-152

Published online

2003-05-27

Bibliographic record

Nucl. Med. Rev 2000;3(2):149-152.

Keywords

radiopharmaceuticals
brain imaging

Authors

Elżbieta Mikiciuk-Olasik
Elżbieta Żurek
Renata Mikołajczak
Edyta Zakrzewska
Katarzyna Błaszczak-Świątkiewicz

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl